ClinicalTrials.govpublic full text
Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy
amyloid cardiomyopathy, enavogliflozin, sodium-glucose cotransporter 2 inhibitor, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 810748
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.